A comparative cerebral blood flow study in a baboon model with acetazolamide provocation: 99mTc-HMPAO vs 123I(IMP).

[1]  D. Oliver,et al.  Drug Effects on Cerebral Blood Flow in the Baboon Model - Acetazolamide and Nimodipine , 1993, Nuklearmedizin.

[2]  D. Oliver,et al.  Dose response from pharmacological interventions for CBF changes in a baboon model using 99Tcm-HMPAO and SPECT. , 1993, Nuclear medicine communications.

[3]  M D Devous,et al.  Dual-isotope brain SPECT imaging with technetium-99m and iodine-123: clinical validation using xenon-133 SPECT. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  M D Devous,et al.  The effect of acetazolamide on regional cerebral blood flow in normal human subjects as measured by single-photon emission computed tomography. , 1988, Investigative radiology.

[5]  R. A. Holmes,et al.  Development of a 99Tcm-labelled radiopharmaceutical for cerebral blood flow imaging , 1985, Nuclear medicine communications.

[6]  P. Jarritt,et al.  A 99Tcm-labelled radiotracer for the investigation of cerebral vascular disease , 1985, Nuclear medicine communications.

[7]  R. A. Holmes,et al.  Cerebral uptake and retention of 99Tcm-hexamethylpropyleneamine oxime (99Tcm-HM‐PAO) , 1985, Nuclear medicine communications.

[8]  R. Baldwin,et al.  Development of I-123-labeled amines for brain studies: localization of I-123 iodophenylalkyl amines in rat brain. , 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  W. Oldendorf,et al.  N-isopropyl-[123I] p-iodoamphetamine: single-pass brain uptake and washout; binding to brain synaptosomes; and localization in dog and monkey brain. , 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1976 .

[11]  R. Luchi,et al.  Quinidine excretion in aciduria and alkaluria. , 1969, Annals of internal medicine.